Subcutaneous interferon β-1a three times weekly and the natural evolution of gadolinium-enhancing lesions into chronic black holes in relapsing and progressive multiple sclerosis: Analysis of PRISMS and SPECTRIMS trials

BACKGROUND: Evolution of gadolinium-enhancing lesions into chronic black holes (CBH) may be reduced by interferon (IFN) therapy. OBJECTIVE: The objective of this paper is to assess the effect of IFN β-1a and placebo on CBH evolution and disability in patients with relapsing–remitting multiple sclero...

Descripción completa

Detalles Bibliográficos
Autores principales: Traboulsee, A, Li, DKB, Tam, R, Zhao, G, Riddehough, A, Fang, J, Dangond, F, Kappos, L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734469/
https://www.ncbi.nlm.nih.gov/pubmed/29276624
http://dx.doi.org/10.1177/2055217317745340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734469/
https://www.ncbi.nlm.nih.gov/pubmed/29276624
http://dx.doi.org/10.1177/2055217317745340

Ejemplares similares